VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) is a publicly traded company in the Unknown sector. Across all available filings, 67 corporate insiders have executed 1000 transactions totaling $2.9B, demonstrating a bearish sentiment with -$1.7B in net insider flow. The most recent transaction on Jun 29, 2018 involved a transaction of 1,344 shares valued at $31.2K.
No significant insider buying has been recorded for VRX in the recent period.
No significant insider selling has been recorded for VRX in the recent period.
Based on recent SEC filings, insider sentiment for VRX is bearish with an Insider Alignment Score of 21/100 and a net flow of -$1.7B. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 67 insiders are actively trading VRX stock, having executed 1000 transactions in the past 90 days. The most active insider is Capital Management, L.p. Valueact (Executive), who has made 24 transactions totaling $1.3B.
Get notified when executives and directors at VRX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jun 29, 2018 | B. Wechsler Amy | Executive | Award | 1,344 | $23.24 | $31.2K | |
| Jun 29, 2018 | C. Robertson Russel | Executive | Award | 1,613 | $23.24 | $37.5K | |
| Jun 29, 2018 | Paulson John | Executive | Award | 1,183 | $23.24 | $27.5K | |
| Jun 29, 2018 | Richard U. De Schutter | Executive | Award | 1,344 | $23.24 | $31.2K | |
| Jun 4, 2018 | Eldessouky Sam | Executive | Payment | 6,142 | $22.08 | $135.6K | |
| May 15, 2018 | Richard U. De Schutter | Executive | Purchase | 10,000 | $21.80 | $218.0K | |
| May 15, 2018 | Richard U. De Schutter | Executive | Purchase | 15,000 | $21.83 | $327.4K | |
| May 3, 2018 | Richard U. De Schutter | Executive | Award | 14,285 | $N/A | $0 | |
| May 3, 2018 | N. Karabelas Argeris | Executive | Award | 14,285 | $N/A | $0 | |
| May 3, 2018 | B. Kavanagh Sarah | Executive | Award | 14,285 | $N/A | $0 | |
| May 3, 2018 | C. Papa Joseph | Executive | Payment | 91,942 | $18.31 | $1.7M | Large |
| May 3, 2018 | Paulson John | Executive | Award | 14,285 | $N/A | $0 | |
| May 3, 2018 | N. Power Robert | Executive | Award | 14,285 | $N/A | $0 | |
| May 3, 2018 | C. Robertson Russel | Executive | Award | 14,285 | $N/A | $0 | |
| May 3, 2018 | W. Ross Thomas Sr | Executive | Award | 14,285 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 53 | $2.3B | 74.0% |
Purchase(P) | 238 | $619.1M | 19.9% |
Disposition(D) | 24 | $55.2M | 1.8% |
Other(J) | 6 | $48.5M | 1.6% |
Payment(F) | 150 | $41.6M | 1.3% |
Exercise(M) | 68 | $18.8M | 0.6% |
Award(A) | 453 | $16.2M | 0.5% |
Exercise (Options)(X) | 1 | $10.0M | 0.3% |
Gift(G) | 7 | $0 | 0.0% |
Insider selling pressure at VALEANT PHARMACEUTICALS INTERNATIONAL has increased, with 67 insiders executing 1000 transactions across all time. Total sales of $2.3B significantly outpace purchases of $619.1M, resulting in a net outflow of $1.7B. This selling activity appears largely discretionary, which may warrant closer attention from investors.